Combined assay for current glucose level and intermediate or long-term glycemic control
AssigneeLXN Corporation
InventorsRobert S. Galen, John F. Burd, Talei Hoblitzell, Gebhard Neyer
Life of this patent
Estimating the term…
Loading patent…
AssigneeLXN Corporation
InventorsRobert S. Galen, John F. Burd, Talei Hoblitzell, Gebhard Neyer
Estimating the term…
The present invention is directed to a single test system and method for determining the integrated glycemic condition of a subject by measuring the concentration of glucose and the level of protein-bound glucose in a subject's body fluid, such as whole blood. The glucose concentration is indicative of the subject's immediate glycemic condition, whereas the protein-bound glucose concentration is indicative of either intermediate or long-term glycemic condition. Optionally, other analytes indicative of glycemic condition, such as ketone bodies or fatty acid derivatives, can also be measured. The present invention also provides a method of diagnosing diabetes. The invention additionally provides a method for analyzing the concentration of fructosamine in less than or equal to five minutes without the use of a reaction accelerator.
A method for determining integrated glycemic condition of a subject with a single test device responsive to a signal producing system indicative of glucose concentration and a signal producing system indicative of fructosamine concentration, consisting of the steps of:
Dependencies are inferred from the claim text.